(Q35058295)

6 August 2017

title

Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease (English)

1 reference

6 August 2017

Justine Bacchetta

7

0 references

Matthias Gondan

object named as

Matthias Gondan

22

0 references

Rukshana Shroff

object named as

Rukshana Shroff

Dagmar-Christiane Fischer

19

0 references

2

object named as

Dagmar-Christiane Fischer

1 reference

6 August 2017

Anke Doyon

1

1 reference

6 August 2017

Aysun Karabay Bayazit

3

1 reference

6 August 2017

Nur Canpolat

4

1 reference

6 August 2017

Ali Duzova

5

1 reference

6 August 2017

Betül Sözeri

6

1 reference

6 August 2017

Ayse Balat

8

1 reference

6 August 2017

Anja Büscher

9

1 reference

6 August 2017

Cengiz Candan

10

1 reference

6 August 2017

Nilgun Cakar

11

1 reference

6 August 2017

Osman Donmez

12

1 reference

6 August 2017

Jiri Dusek

13

1 reference

6 August 2017

Martina Heckel

14

1 reference

6 August 2017

Günter Klaus

15

1 reference

6 August 2017

Sevgi Mir

16

1 reference

6 August 2017

Gül Özcelik

17

1 reference

6 August 2017

Lale Sever

18

1 reference

6 August 2017

Enrico Vidal

20

1 reference

6 August 2017

Elke Wühl

21

1 reference

6 August 2017

Anette Melk

23

1 reference

6 August 2017

Uwe Querfeld

24

1 reference

6 August 2017

Dieter Haffner

25

1 reference

6 August 2017

Franz Schaefer

26

1 reference

6 August 2017

4C Study Consortium

27

1 reference

6 August 2017

language of work or name

English

0 references

publication date

6 February 2015

1 reference

6 August 2017

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

e0113482

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

copyright license

start time

6 February 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Chronic kidney disease: mineral and bone disorder in children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

The relation between renal function and serum sclerostin in adult patients with CKD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

The consequences of chronic kidney disease on bone metabolism and growth in children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Early skeletal and biochemical alterations in pediatric chronic kidney disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Sclerostin levels during growth in children.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

FGF23 in skeletal modeling and remodeling

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Sclerostin and Dickkopf-1 in renal osteodystrophy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Osteocytes and WNT: the mechanical control of bone formation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Does osteocytic SOST suppression mediate PTH bone anabolism?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

8 July 2018

FGF-23 in bone biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

New equations to estimate GFR in children with CKD

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

TRACP as an Osteopontin Phosphatase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Circulating biochemical markers of bone remodeling in uremic patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319910

Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113482

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113482

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113482

Mineralized tissue cells are a principal source of FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113482

The bone and mineral disorder of children undergoing chronic peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113482

Sclerostin: just one more player in renal bone disease?

21 January 2018

1 reference

12 December 2020

Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease

1 reference

12 December 2020

Changes in plasma FGF23 in growth hormone deficient children during rhGH therapy

1 reference

12 December 2020

The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease

1 reference

12 December 2020

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients

1 reference

12 December 2020

Bone alkaline phosphatase in children with chronic renal failure

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0113482

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference